Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma

ConclusionsAE-G-3/4 during AC was associated with a lower RDI and AC completion rate and a worse outcome among patients with PDAC who had received NAC.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research